首页> 外文期刊>Journal of Pharmacopuncture >Effects of Inhalable Microparticles of Seonpyejeongcheon-Tang in an Asthma Mouse Model - Effects of Microparticles of SJT -
【24h】

Effects of Inhalable Microparticles of Seonpyejeongcheon-Tang in an Asthma Mouse Model - Effects of Microparticles of SJT -

机译:善皮正清汤可吸入微粒对哮喘小鼠的影响-SJT微粒的作用-

获取原文
           

摘要

Objectives: Allergic asthma generally presents with symptoms of wheezing, coughing, breathlessness, and airway inflammation. Seonpyejeongcheon-tang (SJT) consists of 12 herbs. It originated from Jeong-cheon-tang (JT), also known as Ding-chuan-tang, composed of 7 herbs, in She-sheng-zhong-miao-fang. This study aimed to evaluate the effects of local delivery of SJT via inhalable microparticles in an asthma mouse model. Methods: Microparticles containing SJT were produced by spray-drying with leucine as an excipient. SJT microparticles were evaluated with respect to their aerodynamic properties, in vitro cytotoxicity, in vivo toxicity, and therapeutic effects on ovalbumin (OVA)-induced asthma in comparison with orally-administered SJT. Results: SJT microparticles provided desirable aerodynamic properties (fine particle fraction of and mass median aerodynamic diameter of ). SJT microparticles did not show any cytotoxicity against RAW 264.7 macrophages at concentrations of 0.01 - 3 mg/mL. Inhaled SJT microparticles decreased the levels of IL-4, IL-5, IL-13, IL-17A, eotaxin and OVA-IgE in bronchoalveolar lavage fluid (BALF) in mice with OVA-induced asthma. These effects were verified by histological evaluation of the levels of infiltration of inflammatory cells and collagen, destructions of alveoli and bronchioles, and hyperplasia of goblet cells in lung tissues. The effects of SJT microparticles in the asthma model were equivalent to those of orally-administered SJT extract. Conclusion: This study suggests that SJT is a promising agent for inhalation therapy for patients with asthma.
机译:目的:过敏性哮喘通常表现为喘息,咳嗽,呼吸困难和气道炎症症状。仙平亭川汤(SJT)由12种草药组成。它起源于社升中苗坊的正天堂(JT),也称为定传堂,由七种草药组成。这项研究旨在评估哮喘小鼠模型中通过可吸入微粒局部递送SJT的效果。方法:以亮氨酸为赋形剂,通过喷雾干燥法制备了含SJT的微粒。与口服SJT相比,评估了SJT微粒的空气动力学特性,体外细胞毒性,体内毒性以及对卵白蛋白(OVA)诱发的哮喘的治疗效果。结果:SJT微粒提供了理想的空气动力学特性(细颗粒分数为,质量中位数空气动力学直径为)。在浓度为0.01-3 mg / mL的条件下,SJT微粒对RAW 264.7巨噬细胞未显示任何细胞毒性。吸入的SJT微粒可降低OVA诱发的哮喘小鼠支气管肺泡灌洗液(BALF)中IL-4,IL-5,IL-13,IL-17A,嗜酸性粒细胞趋化因子和OVA-IgE的水平。通过组织学评估炎性细胞和胶原的浸润水平,肺泡和细支气管的破坏以及肺组织中杯状细胞的增生,证实了这些作用。 SJT微粒在哮喘模型中的作用与口服SJT提取物的作用相同。结论:这项研究表明,SJT是用于哮喘患者吸入治疗的有前途的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号